This new tax will eventually be passed along to us, increasing our health care costs.
So much for reform.
LV Congressman Charlie Dent, joined by Reps. Jim Gerlach (R-PA), Leonard Lance (R-NJ), and Erik Paulsen (R-MN), has proposed an amendment to eliminate this excise tax, which will obviously harm American innovation and cost people jobs.
Dent today told the House Rules Committee that the current bill "will have a detrimental impact on the people of the 15th District of Pennsylvania. Pennsylvania and neighboring New Jersey are home to many employers who lead the world in medical innovation by designing and manufacturing lifesaving equipment. They also provide good jobs for the families in my district.”
According to a Dent news release, companies in his district - like Olympus, OraSure, and Bethlehem–based B. Braun Inc. - will be badly affected. Braun alone will lose $23 million, which is 79 percent of the company’s current research and development investment.
“It’s not just the company itself that suffers,” Congressman Dent said. “The impact of these revenues will imperil jobs; curtail advanced research and innovation; reduce purchasing from Pennsylvania vendors; and hamper investment in capital equipment. The ripple effect on our economy and on working families will be far greater than the sum of the tax. And ultimately, patients will see increased costs as a result.”
Congressman Dent reiterated his opposition to the health care legislation both for its harmful policies and the unfair procedure by which it’s being forced through Congress.
“This is a tax on innovation, patients and the economy,” Congressman Dent said. “As the Wall Street Journal noted, this provision will ‘tax health care to subsidize people to buy health care that new taxes and regulation make more expensive.’ My constituents understand this paradox."